09Q3 6362090 i 6362090-9 2009-09-16 2009-09-18 exp phhy2009br39867 novartis pharmaceutical corporation m true 2009-09-18 cn 2009-08-10 brazil 1012271376 ps exelon 1 transdermal 22083 2009-03-01 1012271377 ss exelon 1 transdermal 022083 2009-03-01 1012271378 c zyprexa 1 oral 2009-02-01 1012271379 c risperdal 1 oral 2009-02-01